DekaBank Deutsche Girozentrale’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,900	Closed	-$379K	–	1496
2021 Q3	$379K	Hold	6,900	–	–	﹤0.01%	1108
2021 Q2	$288K	Hold	6,900	–	–	﹤0.01%	1154
2021 Q1	$282K	Hold	6,900	–	–	﹤0.01%	1126
2020 Q4	$319K	Hold	6,900	–	–	﹤0.01%	1111
2020 Q3	$286K	Buy	+6,900	New	+$302K	﹤0.01%	1001
2019 Q4	–	Sell	-6,900	Closed	-$389K	–	1235
2019 Q3	$389K	Sell	6,900 -6,900	-50%	-$388K	﹤0.01%	797
2019 Q2	$759K	Buy	13,800 +5,300	+62%	+$276K	﹤0.01%	839
2019 Q1	$581K	Buy	8,500 +1,600	+23%	+$71.2K	﹤0.01%	882
2018 Q4	$268K	Sell	6,900 -1,600	-19%	-$82.5K	﹤0.01%	928
2018 Q3	$581K	Sell	8,500 -200	-2%	-$15.2K	﹤0.01%	902
2018 Q2	$661K	Hold	8,700	–	–	﹤0.01%	845
2018 Q1	$454K	Sell	8,700 -200	-2%	-$11.6K	﹤0.01%	882
2017 Q4	$496K	Hold	8,900	–	–	﹤0.01%	822
2017 Q3	$496K	Hold	8,900	–	–	﹤0.01%	828
2017 Q2	$702K	Hold	8,900	–	–	0.01%	769
2017 Q1	$738K	Sell	8,900 -750	-8%	-$55.8K	0.01%	662
2016 Q4	$756K	Buy	9,650 +750	+8%	+$54.5K	0.01%	590
2016 Q3	$623K	Hold	8,900	–	–	0.01%	630
2016 Q2	$346K	Sell	8,900 -400	-4%	-$16.7K	﹤0.01%	755
2016 Q1	$363K	Buy	+9,300	New	+$590K	﹤0.01%	720

Other funds holding EGRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

DekaBank Deutsche Girozentrale's EGRX Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2021, closing a stake of 6,900 shares — an estimated $379K sold.

DekaBank Deutsche Girozentrale first reported a position in EGRX in Q1 2016 and held it in 20 quarters. The position peaked at $759K in Q2 2019. 162 funds tracked by Wall St. Rank hold EGRX as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 6,900 Eagle Pharmaceuticals, Inc. shares in Q4 2021, an estimated $379K.
DekaBank Deutsche Girozentrale first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2016 and held it in 20 quarters.
DekaBank Deutsche Girozentrale's Eagle Pharmaceuticals, Inc. position peaked at $759K in Q2 2019.
162 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.